The S&P 500 has hit yet another all-time high as the key index was last seen up over 13% year-to-date. While this means many stocks are surging to all-time highs, there are actually many stocks that are not participating at all or are now deemed as overvalued by Wall Street. Those may be some stocks that investors will worry about if a market correction comes into play.
Oggonomics has tracked multiple “Sell” and equivalent ratings being issued in the last five trading days. Some of these sell ratings were already cautious, but what does it say when an analyst’s new price target indicates more expected weakness ahead? And those investors who worry that the market may be overextended may look to exit some of their big gainers or get out of stocks they expect to lose money in.
Investors should always keep in mind that Wall Street analysts also rarely issue “Sell” ratings, as demonstrated here:
- FactSet’s analysis of nearly 12,700 stocks shows about 57.5% stock ratings as “buy.”
- About 37.7% have “Hold/Neutral” ratings.
- Only about 4.8% are counted as “Sell” ratings.
- That’s a ratio of nearly 12-to-1 in “Buys” versus “Sells.”
Oggonomics does not ever recommend that investors simply chase daily ratings and price target changes solely based on Wall Street research reports alone. That said, it sure stands out when analysts are raising red flags for a stock to drop when everyone assumes Wall Street is always trying to look for a bullish case.
6 FRESH “SELL” RATINGS
Here are the top “Sell” ratings, or their equivalents, listed in alphabetical order over the five days up to August 5, 2026.
Clorox (CLX) reported earnings on August 3 and was reiterated as Underperform at Evercore ISI after the report. While the price target was bumped up to $99 from $98 in the call, its shares were last seen at $104 with a 52-week range of $84.70 – $128.90. The consumer products player’s shares are up just 3% year-to-date.
Duolingo (DUOL) is down over 20% year-to-date, but a pre-earnings downgrade was seen when BofA Securities cut its rating to Underperform from Neutral on August 4. The firm also slashed its price objective to $93 from $103, indicating even more downside from its $135 level before earnings. The language-learning website and mobile application provider’s 52-week range of $87.89 to $468 spells out how much pain there is on top of poor performance just in 2026.
ALSO READ: TOP CHIP CAPEX STOCKS TO BUY NOW
eBay Inc. (EBAY) may have recovered in 2026 with its shares up 25% year-to-date, but Wells Fargo issued a pre-earnings “sell” rating in anticipation of the report. On August 3, Wells Fargo cut its rating to Underweight from Equal-Weight and cut the price target to $92 from $105. Its shares were last seen at $105 with a 52-week range of $78.03 to $119.31. The firm cut earnings by 10% for the year based on dilution from a recent acquisition of Depop and continued competitive threats that may nibble into the eBay dominance. Wells Fargo also sees earnings and 2026 guidance coming in under expectations.
Illumina Inc. (ILMN) was reiterated as Sell at Citigroup on August 3. While this Sell rating is never good to see, Illumina’s stock was at a 52-week high and the shares were up 53% year-to-date. With shares at $200, Illumina’s price target was actually raised to $113 from $105 in Citi’s call. So far Citi has been quite wrong and other some of the other analysts covering Illumina continue to see more upside to their price targets.
Nike Inc. (NKE) was downgraded to Underweight from Neutral on August 4, and the price target was cut to $40 from an already unimpressive $47 prior price target at JPMorgan. Nike fell 2.6% to $41.53 on the day of the downgrade. The stock’s 52-week range of $40.00 – $80.17 is almost descriptive enough of the pain shareholders are feeling, at least until considering an all-time high over $160 back in 2021. The analyst sees Nike’s financial impacts weighing on the stock as its turnaround strategy appears to not be working. And the sporting apparel’s “Win Now” strategy will likely linger and continue to hurt profits and earnings in the second half of 2027 and even into fiscal year 2028. Not exactly a ringing endorsement.
ALSO READ: IS APPLE SET TO LOST $1 TRILLION IN VALUE?
Roblox (RBLX) continues to punish shareholders in 2026 as its recent earnings report disappointed investors with slowing revenue growth and after withdrawing guidance for the year. The shares fell over 25% on its last results and class action lawsuits may prove to be a continued overhang ahead. While some analysts have stubbornly maintained Buy and Outperform ratings, on July 31 Benchmark cut its rating to Sell from Hold and BTIG downgraded it to Sell from Neutral. Roblox was last seen at $37.00 and the 52-week range is $33.88 to $142.00. Its shares are down over 50% year-to-date.
DISCLAIMER
All analyst ratings and price targets have been assigned to the firms named in this reporting. Be advised that other analysts may hold more favorable or less-negative views than the ratings featured here. Oggonomics does not issue formal ratings and price targets of its own. And lastly — don’t forget that analyst reports never come with money-back guarantees if their recommendations do not come to fruition.
